275 related articles for article (PubMed ID: 24475824)
1. Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient.
Donati OF; Mazaheri Y; Afaq A; Vargas HA; Zheng J; Moskowitz CS; Hricak H; Akin O
Radiology; 2014 Apr; 271(1):143-52. PubMed ID: 24475824
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of multiparametric prostate MR images: differentiation between prostate cancer and normal tissue and correlation with Gleason score--a computer-aided diagnosis development study.
Peng Y; Jiang Y; Yang C; Brown JB; Antic T; Sethi I; Schmid-Tannwald C; Giger ML; Eggener SE; Oto A
Radiology; 2013 Jun; 267(3):787-96. PubMed ID: 23392430
[TBL] [Abstract][Full Text] [Related]
3. Texture features on T2-weighted magnetic resonance imaging: new potential biomarkers for prostate cancer aggressiveness.
Vignati A; Mazzetti S; Giannini V; Russo F; Bollito E; Porpiglia F; Stasi M; Regge D
Phys Med Biol; 2015 Apr; 60(7):2685-701. PubMed ID: 25768265
[TBL] [Abstract][Full Text] [Related]
4. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer.
Hambrock T; Somford DM; Huisman HJ; van Oort IM; Witjes JA; Hulsbergen-van de Kaa CA; Scheenen T; Barentsz JO
Radiology; 2011 May; 259(2):453-61. PubMed ID: 21502392
[TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness.
Vargas HA; Akin O; Franiel T; Mazaheri Y; Zheng J; Moskowitz C; Udo K; Eastham J; Hricak H
Radiology; 2011 Jun; 259(3):775-84. PubMed ID: 21436085
[TBL] [Abstract][Full Text] [Related]
6. [Discussion of correlation between histogram analysis of quantitative diffusion weighted imaging and Gleason score of prostate cancer].
Wen R; Zhao WL; Wei CG; Gu YF; Li MJ; Zhang YY; Shen JK
Zhonghua Yi Xue Za Zhi; 2019 Mar; 99(11):823-828. PubMed ID: 30893724
[No Abstract] [Full Text] [Related]
7. Characterization of breast masses as benign or malignant at 3.0T MRI with whole-lesion histogram analysis of the apparent diffusion coefficient.
Suo S; Zhang K; Cao M; Suo X; Hua J; Geng X; Chen J; Zhuang Z; Ji X; Lu Q; Wang H; Xu J
J Magn Reson Imaging; 2016 Apr; 43(4):894-902. PubMed ID: 26343918
[TBL] [Abstract][Full Text] [Related]
8. Comparison of PI-RADS 2, ADC histogram-derived parameters, and their combination for the diagnosis of peripheral zone prostate cancer.
Lin WC; Westphalen AC; Silva GE; Chodraui Filho S; Reis RB; Muglia VF
Abdom Radiol (NY); 2016 Nov; 41(11):2209-2217. PubMed ID: 27364781
[TBL] [Abstract][Full Text] [Related]
9. [Stretched-exponential and mono-exponential diffusion-weighted imaging for assessing the aggressiveness of prostate cancer: A histogram analysis].
Yu YN; Zhang SJ
Zhonghua Nan Ke Xue; 2019 Dec; 25(12):1106-1112. PubMed ID: 32251563
[TBL] [Abstract][Full Text] [Related]
10. Histogram analysis of diffusion kurtosis magnetic resonance imaging in differentiation of pathologic Gleason grade of prostate cancer.
Wang Q; Li H; Yan X; Wu CJ; Liu XS; Shi HB; Zhang YD
Urol Oncol; 2015 Aug; 33(8):337.e15-24. PubMed ID: 26048104
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
12. Quantitative Analysis of Prostate Multiparametric MR Images for Detection of Aggressive Prostate Cancer in the Peripheral Zone: A Multiple Imager Study.
Hoang Dinh A; Melodelima C; Souchon R; Lehaire J; Bratan F; Mège-Lechevallier F; Ruffion A; Crouzet S; Colombel M; Rouvière O
Radiology; 2016 Jul; 280(1):117-27. PubMed ID: 26859255
[TBL] [Abstract][Full Text] [Related]
13. Histogram analysis of diffusion kurtosis imaging in the differentiation of malignant from benign breast lesions.
Liu W; Wei C; Bai J; Gao X; Zhou L
Eur J Radiol; 2019 Aug; 117():156-163. PubMed ID: 31307642
[TBL] [Abstract][Full Text] [Related]
14. Transition zone prostate cancer: incremental value of diffusion-weighted endorectal MR imaging in tumor detection and assessment of aggressiveness.
Jung SI; Donati OF; Vargas HA; Goldman D; Hricak H; Akin O
Radiology; 2013 Nov; 269(2):493-503. PubMed ID: 23878284
[TBL] [Abstract][Full Text] [Related]
15. Whole-Tumor Quantitative Apparent Diffusion Coefficient Histogram and Texture Analysis to Predict Gleason Score Upgrading in Intermediate-Risk 3 + 4 = 7 Prostate Cancer.
Rozenberg R; Thornhill RE; Flood TA; Hakim SW; Lim C; Schieda N
AJR Am J Roentgenol; 2016 Apr; 206(4):775-82. PubMed ID: 27003049
[TBL] [Abstract][Full Text] [Related]
16. Preoperative Evaluation of Prostate Cancer Aggressiveness: Using ADC and ADC Ratio in Determining Gleason Score.
Woo S; Kim SY; Cho JY; Kim SH
AJR Am J Roentgenol; 2016 Jul; 207(1):114-20. PubMed ID: 27077643
[TBL] [Abstract][Full Text] [Related]
17. The performance of intravoxel-incoherent motion diffusion-weighted imaging derived hypoxia for the risk stratification of prostate cancer in peripheral zone.
Chen Z; Xue Y; Zhang Z; Li W; Wen M; Zhao Y; Li J; Weng Z; Ye Q
Eur J Radiol; 2020 Apr; 125():108865. PubMed ID: 32058895
[TBL] [Abstract][Full Text] [Related]
18. Prostate Cancer: Utility of Whole-Lesion Apparent Diffusion Coefficient Metrics for Prediction of Biochemical Recurrence After Radical Prostatectomy.
Rosenkrantz AB; Ream JM; Nolan P; Rusinek H; Deng FM; Taneja SS
AJR Am J Roentgenol; 2015 Dec; 205(6):1208-14. PubMed ID: 26587927
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy.
Woodfield CA; Tung GA; Grand DJ; Pezzullo JA; Machan JT; Renzulli JF
AJR Am J Roentgenol; 2010 Apr; 194(4):W316-22. PubMed ID: 20308476
[TBL] [Abstract][Full Text] [Related]
20. Histogram analysis of MR quantitative parameters: are they correlated with prognostic factors in prostate cancer?
Chen Y; Meng T; Cao W; Zhang W; Ling J; Wen Z; Qian L; Guo Y; Lin J; Wang H
Abdom Radiol (NY); 2024 May; 49(5):1534-1544. PubMed ID: 38546826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
